Exoskeleton technology used in double lung transplant in world first trial

After the operation, surgeon Mr Espeed Khoshbin commented: “Using the exoskeleton suit, including taking it on and off, was remarkably straightforward.

“The suit was comfortable throughout the procedure and I felt a significant reduction in my upper body strain.

“This is important because so many cardiothoracic and transplant surgeons suffer from neck and back-related musculoskeletal issues which can negatively impact their careers.

“Our patient is progressing very well and recovering swiftly from her surgery.”

The trial has been spearheaded by Mr Aamir Amin, Cardiothoracic Surgical Resident and Honorary Research Fellow at the hospital, working in collaboration with Hertfordshire based Health and Safety consultants, Stanley, who advised on the best equipment to trial, supplied the HAPO exoskeleton suit and provided suitable training to the surgical team.

Graham Sharp, Managing Director of Stanley said: “We’re thrilled with the success of the trial and how effectively the exoskeleton suit supported the demands of a long surgical procedure.

We have seen a lot of success with this AI wearable technology in a range of health care settings, including in care homes, where carers are moving and lifting patients on a regular basis.

“Our role in this trial has been to advise on the best technology for this type of procedure and subsequent training and supply of the HAPO exoskeleton.

“AI wearable technology is proving to be game changing for the Health and Safety sector in the UK, with equipment like lightweight exoskeleton suits and wearable SmartBelts, able to help cut accident and injury rates in UK workplaces.”